FROM YAHOO NEWS Latest news, live updates as 2024 election results loom NasdaqCM - Nasdaq Real Time Price ? USD Avid Bioservices, Inc. (CDMO) Follow Compare 10.54 +0.20 (+1.93%) At close: November 5 at 4:00 PM EST 10.54 0.00 (0.00%) After hours: November 5 at 4:03 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations State Street Corp's Strategic Reduction in Avid Bioservices Inc Holdings On September 30, 2024, State Street Corp executed a significant transaction involving the shares of Avid Bioservices Inc (NASDAQ:CDMO), a key player in the biopharmaceutical sector. State Street Corp, headquartered at One Lincoln Street, Boston, MA, is a prominent financial services provider known for its robust investment strategies. The firm manages a diverse portfolio with a strong emphasis on technology and financial services, holding significant positions in major companies like Apple Inc (NASDAQ:AAPL) and Amazon.com Inc (NASDAQ:AMZN). GuruFocus.com ? 19 days ago CDMO +1.93% STT Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the upcoming Craig-Hallum Bioprocessing Conference. Nick Green, president and chief executive officer, and Pramthesh Patel, Ph.D., GlobeNewswire ? last month CDMO +1.93% Avid Bioservices First Quarter 2025 Earnings: Misses Expectations Avid Bioservices ( NASDAQ:CDMO ) First Quarter 2025 Results Key Financial Results Revenue: US$40.2m (up 6.5% from 1Q... Simply Wall St. ? last month CDMO +1.93% Q1 2025 Avid Bioservices Inc Earnings Call Q1 2025 Avid Bioservices Inc Earnings Call Thomson Reuters StreetEvents ? last month CDMO +1.93% HALO Avid Bioservices: Fiscal Q1 Earnings Snapshot CDMO) on Monday reported a loss of $5.5 million in its fiscal first quarter. The Tustin, California-based company said it had a loss of 9 cents per share. Losses, adjusted for stock option expense and non-recurring costs, came to 3 cents per share. Associated Press Finance ? last month CDMO +1.93% Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 -- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160 Million and $168 Million -- TUSTIN, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechno GlobeNewswire ? last month CDMO +1.93% Avid Bioservices, Inc. (CDMO): This Small-Cap Healthcare Stock Is A Good Buy Right Now We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Avid Bioservices, Inc. (NASDAQ:CDMO) stands against the other small-cap healthcare stocks. Healthcare Sector: A Defensive Investment with Growth Potential in 2024 In difficult economic times, healthcare equities are sometimes […] Insider Monkey ? last month CDMO +1.93% Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the first quarter of fiscal year 2025 on September 9, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time). Member GlobeNewswire ? 2 months ago CDMO +1.93% Does Avid Bioservices (CDMO) have Hidden Potential Despite Current Weakness? Laughing Water Capital, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, Class A interests in Laughing Water Capital returned about 2.5% bringing year-to-date returns to 11.1%. The SP500TR and R2000 returned 4.3% and -3.3% in the second quarter and 15.3% […] Insider Monkey ? 3 months ago CDMO +1.93% Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 -- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditure Associated with Three-Year Expansion Program Completed -- -- FY 2025 Revenue Guidance of Between $160 Million and $168 Million -- TUSTIN, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedic GlobeNewswire ? 4 months ago CDMO +1.93% Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time). GlobeNewswire ? 4 months ago CDMO +1.93% Those who invested in Avid Bioservices (NASDAQ:CDMO) five years ago are up 104% The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put... Simply Wall St. ? 4 months ago CDMO +1.93% Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler We recently compiled the list of the Analysts on Wall Street Lower Ratings for These 10 Stocks. In this article, we are going to take a look at where Halozyme Therapeutics, Inc. (NASDAQ:HALO) stands against the other stocks that received a downgrade from Wall Street analysts. But first, we are going to take a look at […] Insider Monkey ? 4 months ago HALO CDMO +1.93% Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company has achieved a Committed Badge from EcoVadis, one of the world’s most trusted providers of business sustainability ratings. Avid earned a score of 56 fro GlobeNewswire ? 5 months ago CDMO +1.93% Avid Bioservices to Participate at Upcoming Investor Conferences TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate at two upcoming investor conferences. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat GlobeNewswire ? 5 months ago CDMO +1.93% How Novo-Catalent Deal Affects Halozyme (HALO)? Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, investment in the fund returned 8.4% after all fees and expenses compared to 10.6% and 5.2% returns for the SP500TR and R2000 during the quarter, respectively. In addition, you […] Insider Monkey ? 6 months ago HALO CTLT CDMO +1.93% Q3 2024 Avid Bioservices Inc Earnings Call Q3 2024 Avid Bioservices Inc Earnings Call Thomson Reuters StreetEvents ? 6 months ago CDMO +1.93% Avid Bioservices Inc (CDMO) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges ... Explore the detailed financial performance and strategic responses of Avid Bioservices in the face of declining revenues and margins. GuruFocus.com ? 6 months ago CDMO +1.93% Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 -- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 2024 -- -- Completed Convertible Debt Offering Subsequent to Quarter End, Extending Debt Maturity to 2029 -- TUSTIN, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics GlobeNewswire ? 6 months ago CDMO +1.93% Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received a notice (the “Notice”) on March 19, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure t GlobeNewswire ? 7 months ago CDMO +1.93% Performance Overview Trailing total returns as of 11/5/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return CDMO S&P 500 YTD +62.15% +21.24% 1-Year +62.40% +32.68% 3-Year -68.14% +23.56%
